CDKN2A and colon adenocarcinoma: Consequently, we studied the clinical and pathological parameters in UALCAN of CDKN2A in COAD intensively and the findings showed that it was statistically different in terms of race, it was significant in Caucasians and African Americans as shown in Figure 4A because it could diagnose both genders with higher risk to males than females without noticing any significant difference comparing both genders (Figure 4B).